Publication | Closed Access
A Phase 2 Study with Epirubicin as Second-Line Treatment of Patients with Advanced Epithelial Ovarian Cancer
15
Citations
0
References
1996
Year
Second-line TreatmentMedicineGynecologyCancer TreatmentPhase 2OncologyRadiation OncologyGynecology OncologyEndocrine-related CancerOvarian Cancer
No additional data available for this publication yet. Check back later!